|
|
|
|
|
|
|
|
|
|
|
|
Nr. |
Autoren |
|
Titel |
|
|
|
|
|
|
|
|
|
|
|
|
MG01 |
Anagnostou S.; Lardos A. |
|
Historische Arzneipflanzenanalyse eine Option für die moderne Phytotherapie |
|
|
|
|
|
|
|
|
|
|
|
|
MG02 |
Bisping M.; Anagnostou S. |
|
Weizen mehr als nur ein Nahrungsmittel? Historische Traditionen und moderne phytotherapeutische Optionen |
|
|
|
|
|
|
|
|
|
|
|
|
MG03 |
Schuster N.; Anagnostou S. |
|
Traditionelle Febrifuga potentielle Phytotherapeutika? |
|
|
|
|
|
|
|
|
|
|
|
|
EM04 |
Rieder A.; Guarim Neto G. |
|
Diversity of plants used for diabetes control in Mato Grosso, Brazil |
|
|
|
|
|
|
|
|
|
|
|
|
QK05 |
Camps C.; Gérard M.; Simonnet X.; Quennoz M.; Brabant C.; Oberson C.; Carlen C. |
|
Prediction of essential oil content of oregano by handheld and Fourier transform NIR spectroscopy |
|
|
|
|
|
|
|
|
|
|
|
|
QK06 |
Feistel B.; Kurth H.; Schlicht C. |
|
Analytische Differenzierung von Extrakten aus den Wurzeln von Rhodiola rosea vs. Rhodiola crenulata |
|
|
|
|
|
|
|
|
|
|
|
|
QK07 |
Weinfurter K.; Pemp E.; Weber N.; Krenn L. |
|
Qualitätskontrolle von Rotklee- und Rotklee-Soja-Präparaten |
|
|
|
|
|
|
|
|
|
|
|
|
QK08 |
Murtaj V.; Krienbühl H.; Leng A.; Meier B. |
|
Optimization and validation of an automated sample preparation of an herbal drug on the basis of a Solid-Phase-Extraction |
|
|
|
|
|
|
|
|
|
|
|
|
QK09 |
Kisseleff N.; Schmid T.; Ryffel J.; Lapke C. |
|
Flavonoide in Glycerolmazeraten von Ribes nigrum L. |
|
|
|
|
|
|
|
|
|
|
|
|
QK10 |
Kisseleff N.; Schmid T.; Ryffel J.; Lapke C. |
|
Freie Aminosäuren in Glycerolmazeraten von Ribes nigrum L. |
|
|
|
|
|
|
|
|
|
|
|
|
QK11 |
Wolfram E.; Meier B.; Danova K. |
|
Development of Biotechnological Protocols in Medicinal Plant Research Contribution for Safeguarding and Standardization of Raw Material for Phytotherapy using Hypericum species Indigenous to the Balkan Region |
|
|
|
|
|
|
|
|
|
|
|
|
QK12 |
Bräm S.; Meier B.; Danova K.; Wolfram E. |
|
Bioautographic Xanthine Oxidase Assay: Combining phytochemical separation and activity assessment as a tool for medicinal plant research |
|
|
|
|
|
|
|
|
|
|
|
|
QK13 |
Wüthrich J.; Peter S.; Wolfram E.; Meier B. |
|
Wässrige Extraktion von Sennosid A und B: Untersuchungen zur Herstellung von Sirupus caricae comp. nach Ph. Helv. |
|
|
|
|
|
|
|
|
|
|
|
|
QK14 |
Potterat O.; Seiler C.; Gerodetti M.; Oufir M.; Fürer K.; Mennet-von Eiff M.; Brenneisen R.; Mandach U.; Hamburger M. |
|
Quantification of Bufadienolides in Bryophyllum pinnatum Leaves and Manufactured Products |
|
|
|
|
|
|
|
|
|
|
|
|
PK15 |
Jähne E.A.; Oufir M.; Eigenmann D.E.; Butterweck V.; Hamburger M. |
|
Pharmacokinetics and In Vitro Blood-Brain Barrier Screening of an Anti-inflammatory Indolinone from Isatis tinctoria |
|
|
|
|
|
|
|
|
|
|
|
|
PK16 |
Wegner I.; Suter A.; Schlotterbeck G. |
|
Eine neue, hochsensitive LC-MS Methode zum Nachweis der Bioverfügbarkeit von Alkylamiden aus Echinacea in humanen Trockenblutproben |
|
|
|
|
|
|
|
|
|
|
|
|
KU17 |
Szopa A.; Ekiert H. |
|
Cell cultures of three medicinal plant species as a source of therapeutically important phenolic acids |
|
|
|
|
|
|
|
|
|
|
|
|
PH18 |
Nausch B.; Künstle G.; Haunschild J. |
|
Canephron® N reduced nociception in experimental cystitis and inhibited the pain-related targets NK1 receptor and ASIC1a. |
|
|
|
|
|
|
|
|
|
|
|
|
PH19 |
Kelber O.; Okpanyi S.; Abdel-Aziz H. |
|
Phytotherapie beim Reizmagen- und Reizdarm-Syndrom: Wie wirkt Iberogast auf die Motilität von Magen und Darm? |
|
|
|
|
|
|
|
|
|
|
|
|
PH20 |
Khayyal M.; Kelber O.; Abdel-Aziz H. |
|
Evidence for the therapeutic usefulness of an herbal preparation, STW 5, in radiation induced mucositis |
|
|
|
|
|
|
|
|
|
|
|
|
PH21 |
Wedler J.; Schlotterbeck G.; Butterweck V. |
|
Wound healing effects of extracts and major single compounds of Phyllostachys edulis on 3T3-swiss albino fibroblasts |
|
|
|
|
|
|
|
|
|
|
|
|
PH22 |
Vissiennon C.; Jente R; Goos K-H.; Goos O.; Arnhold J.; Nieber K. |
|
Reduction of LPS-induced TNFα-release from THP-1-cells by extracts of Myrrh, Chamomile flower and Coffee charcoal |
|
|
|
|
|
|
|
|
|
|
|
|
PH23 |
Kelber O.; Okpanyi S.; Weiser D.; Abdel-Aziz H. |
|
From the joint to the brain and back Inflammation as link between depression, rheumatism and irritable bowel syndrome |
|
|
|
|
|
|
|
|
|
|
|
|
PH24 |
Rauwald H.; Kuchta K.; Savtschenko A.; Brückner A.; Rusch C.; Appel K. |
|
Interaction of standardized Leonurus cardiaca and L. japonicus extracts as well as their isolated constituents with the GABAA receptor |
|
|
|
|
|
|
|
|
|
|
|
|
PH25 |
Shu J.C.; Kuchta K.; Lin Y.; He Y.J.; Lv X.; Kobayashi Y. |
|
Curcumin induces apoptosis in hepatic stellate cells by modulating the expression of apoptosis related growth factors |
|
|
|
|
|
|
|
|
|
|
|
|
PH26 |
Kuchta K.; Wang R.; Lin Y.; Fang L.; Qiao H. |
|
A phytosterol enriched refined extract of Brassica campestris L. pollen significantly improves benign prostatic hyperplasia (BPH) in a rat model |
|
|
|
|
|
|
|
|
|
|
|
|
PH27 |
Grzebyk E.; Vennos C.; Piwowar A. |
|
The Tibetan herbal formulas Padma 28 and Padma Circosan inhibit the formation of advanced glycation end products and advanced oxidation protein products in vitro |
|
|
|
|
|
|
|
|
|
|
|
|
KS28 |
Meier R.; Hengstler P.; Vennos C.; Brignoli R. |
|
Wirksamkeit des Tibetischen Arzneimittels Padma Digestin bei funktioneller Dyspepsie |
|
|
|
|
|
|
|
|
|
|
|
|
KS29 |
Kuchta K.; Li S.; Tamaru N.; Lin Y.; Iwasaki S.; Wang R.; Kobayashi Y. |
|
Open-label clinical pilot-study on an herbal multicomponent topical TCM therapy for atopic dermatitis and comorbid conditions like psoriasis, acne, alopecia, as well as fungal, bacterial, and viral skin infections |
|
|
|
|
|
|
|
|
|
|
|
|
KS30 |
Watanabe E.; Kuchta K.; Rauwald H.; Kamei T.; Imanishi J. |
|
Randomized cross-over trial on mood enhancing effects of bergamot (Citrus bergamia (Risso) Wright & Arn.) volatile oil vapor, also regarding personality and lifestyle related changes in salivary cortisol levels |
|
|
|
|
|
|
|
|
|
|
|
|
KS31 |
Watanabe E.; Kuchta K.; Rauwald H.; Kamei T.; Imanishi J. |
|
Open-label clinical pilot study on the application of traditional Japanese “Maccha” type green tea (Camellia sinensis (L.) Kuntze) from Uji for metabolic syndrome therapy |
|
|
|
|
|
|
|
|
|
|
|
|
KS32 |
Watanabe E.; Kuchta K.; Kimura M.; Rauwald H.; Kamei T.; Imanishi J. |
|
Evaluation of the fatigue reducing effects of Japanese green tea (Camellia sinensis (L.) Kuntze) from Uji in a randomized cross-over human trial |
|
|
|
|
|
|
|
|
|
|
|
|
KS33 |
Eltbogen R.; Litschgi M.; Gasser U.E.; Nebel S.; Zahner C. |
|
Vitex Agnus-Castus Extract (Ze 440) Improves Symptoms in Women with Menstrual Cycle Irregularities |
|
|
|
|
|
|
|
|
|
|
|
|
KS34 |
Nebel S.; Kobi C.; Zahner C. |
|
Effektive Behandlung der frühen allergischen und späten entzündlichen Symptome der allergischen Rhinitis mit Ze 339 (Tesalin® n): Ergebnisse eines Praxiserfahrungsberichtes |
|
|
|
|
|
|
|
|
|
|
|
|
KS35 |
Simon D.; Eng P.; Borelli S.; Kägi R.; Zahner C.; Ferrari G.; Lautenschlager S.; Wüthrich B.; Schmid-Grendelmeier P. |
|
Gamma-Linolenic Acid Levels Correlate with Clinical Efficacy of Evening Primrose Oil in Patients with Atopic Dermatitis |
|
|
|
|
|
|
|
|
|
|
|
|
KS36 |
Henneicke-von Zepelin HH.; Naser B.; Garcia de Arriba S.; Nolte KU.; Pickartz S. |
|
Key Point for Clinical Efficacy Evaluation of Cimicifuga racemosa |
|
|
|
|
|
|
|
|
|
|
|
|
KS37 |
Marquardt P.; Kraft K.; Nieber K. |
|
Clinical studies on herbal remedies in children: A systematic literature analysis |
|
|
|
|
|
|
|
|
|
|
|
|
KS38 |
Matthys H.; Malek F.A.; Kamin W. |
|
EPs® 7630 in acute respiratory tract infections a systematic review and meta-analysis of randomised clinical trials |
|
|
|
|
|
|
|
|
|
|
|
|
KS39 |
Kraft K.; Kelber O; Okpanyi S.; Müller J. |
|
Phytopharmaka in den Leitlinien: Roßkastanienextrakt als „well established use“-Arzneimittel bei chronisch-venöser Insuffizienz |
|
|
|
|
|
|
|
|
|
|
|
|
SA40 |
Kraft K.; Kelber O.; Schmidt M. |
|
No problem in hypertensive patients? A re-evaluation of the literature data on Eleutherococcus senticosus, radix |
|
|
|
|
|
|
|
|
|
|
|
|
SIG41 |
Kelber O.; Abdel-Aziz H.; Okpanyi S.; Ulrich-Merzenich G. |
|
1 + 1 ≠ 2: Gene expression profiling als neuer Ansatz für die Begründung von Kombinationen |
|
|
|
|
|
|
|
|
|
|
|
|
SIG42 |
Gostner JM.; Naschberger M.;
Hochleitner J.; Becker K.; Gruber P.; Ueberall F. |
|
Transcriptional signatures of multicomponent preparations |
|
|
|
|
|
|
|
|
|
|
|
|
SIG43 |
Becker K.; Schroecksnadel S.; Jenny M.; Fuchs D.; Ueberall F.; Gostner JM. |
|
Ayurvedic myrobalane extracts interfere with inflammatory signalling cascades in THP-1 cells |
|
|
|
|
|
|
|
|
|
|
|
|
SIG44 |
Naschberger M.; Hochleitner J.; Jenny M.; Becker K.; Ueberall F.; Gostner JM. |
|
Effect of Padma 28 on Nrf-2/ARE signalling in HepG2 cells |
|
|
|
|
|
|
|
|
|
|
|
|
ZU45 |
Neidel J.; Mütze A.; Beck-Piotraschke K. |
|
Tussidermil® N ein apothekenpflichtiges phytotherapeutisches Präparat (Emulsion; Wirkstoff: 10% Eucalyptusöl) im Wandel deutscher als auch europäischer Arzneimittelgesetzgebung |
|
|
|
|
|
|
|
|
|
|
|
|
ZU46 |
Silber-Mankowsky A.; Wegener T. |
|
Forschung mit Phytopharmaka unter Berücksichtigung der Aktivitäten des HMPC |
|
|
|
|
|
|
|
|
|
|
|
|
ZU47 |
Wegener T. |
|
Methodische und Regulatorische Aspekte von nichtinterventionellen Prüfungen (NIS) mit Phytopharmaka |
|
|
|
|
|
|
|
|
|
|
|
|
PL48 |
Zahradnicek S. |
|
Pleiotropie von Minzen Mehr als Vielstofflichkeit? |
|
|
|
|
|
|
|
|
|
|
|
|
VET49 |
Axmann S.; Hummel K.; Nöbauer K.; Razzazi-Fazeli E.; Franz Ch.; Zitterl-Eglseer K. |
|
Determination and pharmacokinetic data of harpagoside in equine plasma after intragastric administration of an extract of Harpagophytum procumbens (Devil´s claw) by means of LC/MS/MS |
|
|
|
|
|
|
|
|
|
|
|
|
VET50 |
Bubenhofer R.; Kupper J.; Demuth D.; Nägeli HP. |
|
Pflanzliche Arzneimittel on-line ein Projekt |
|
|
|
|
|
|
|
|
|
|
|
|
VET51 |
Simonnet X.; Quennoz M.; Carlen C. |
|
Phytochemical variability of common tansy |
|
|
|
|
|
|
|
|
|
|
|
|
VET52 |
Dorn K.; Sundrum A.; Leiber F.; Holinger M.; Mayer P.; Walkenhorst M. |
|
Effects of a herbal extract in addition to a standard therapy on short term development of subclinical ketosis |
|
|
|
|
|
|
|
|
|
|
|
|
VET53 |
Groot M.; Kleijer-Ligtenberg G.; Puls I.; Hansma H.; van Asseldonk T. |
|
Guides for farmers to keep their animals healthy with herbs and other natural products. |
|
|
|
|
|
|
|
|
|
|
|
|
VET54 |
Hagmüller W.; Minihuber U. |
|
Eichenrindentee als Hausmittel zur Prophylaxe des Absetzdurch-falls bei zwei unterschiedlichen Fütterungsstrategien für Bioferkel |
|
|
|
|
|
|
|
|
|
|
|
|
VET55 |
Hahn-Ramssl I.; Franz C.; Kranzl A. |
|
Einsatz von Malventee bzw. NaCl bei Vollhautwunden im klinisch-experimentellen Mäuseversuch zum Vergleich der Heilungsdauer |
|
|
|
|
|
|
|
|
|
|
|
|
VET56 |
Hahn-Ramssl I.; Zitterl-Eglseer K.; Franz C.; Ille N.; Pommer E. |
|
Thermografische Untersuchung und Plasmaanalyse nach Zufütterung von Ginkgo biloba-Extrakt (EGb 761) bei Pferden |
|
|
|
|
|
|
|
|
|
|
|
|
VET57 |
Hoby S.; Wenker C. |
|
The use of Hypericum perforatum L. to facilitate introduction of a captive Sumatran orangutan (Pongo abelii) |
|
|
|
|
|
|
|
|
|
|
|
|
VET58 |
Kleijer-Ligtenberg G.; Van Asseldonk T.; Groot M.; Halkes B.; Binnendijk G.; Wagenaar J.; Fink-Gremmels J. |
|
Herbal products for pig health |
|
|
|
|
|
|
|
|
|
|
|
|
VET59 |
Podstatzky L. |
|
Parasite regulation in small ruminants: potential of herbal mixtures |
|
|
|
|
|
|
|
|
|
|
|
|
VET60 |
Pommer E.; Zitterl-Eglseer K; Pacher T.;Schramel P.; Lischka B.; Van den Hoven R. |
|
Pharmacokinetics of Petasites hybridus (Petzell®) extract after oral administration in healthy horses |
|
|
|
|
|
|
|
|
|
|
|
|
VET61 |
Stadtlander T.; Bradley K. |
|
Effects of alcoholic extracts of various plants against Saprolegnia parasitica |
|
|
|
|
|
|
|
|
|
|
|
|
VET62 |
Köstelbauer A.; Teichmann K.; Schatzmayr G. |
|
Alternatives to antibiotics for prevention of porcine intestinal adenomatosis (PIA) |
|
|
|
|
|
|
|
|
|
|
|
|
VET63 |
Vollstedt S. |
|
The Chinese Recipe “Stomach Happy” alleviates Symptoms related to the Chinese Stomach Complex in Horses |
|
|
|
|
|
|
|
|
|
|
|
|
VET64 |
Zitterl-Eglseer K.; Haselmeyer A.; Kolodziejek J.; Heistinger H.; Nöbauer K.; Nowotny N. |
|
First results of diets containing lemon balm extract (Melissa officinalis L.) or rosmarinic acid against Cyprinid herpesvirus 3 (CyHV-3) infections in koi carp (Cyprinus carpio koi) |
|
|
|
|
|
|
|
|